Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy

Journal of Urology

Volumn 188, Issue 1, 2012, Pages 58-62

  Grossman, H Barton ^a   Stenzl, Arnulf ^b   Fradet, Yves ^e   Mynderse, Lance A ^f   Kriegmair, Martin ^c   Witjes, J Alfred ^g   Soloway, Mark S ^h   Karl, Alexander ^a   Burger, Maximilian ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Urology Clinic   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF QUEBEC   (Canada)

^f MAYO CLINIC   (United States)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

5 aminolevulinic acid hexyl ester; cystoscopy; fluorescence; local; neoplasm recurrence; urinary bladder neoplasms

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; BCG VACCINE;

ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; FLUORESCENCE CYSTOSCOPY; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; ORGAN PRESERVATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; WHITE LIGHT ENDOSCOPY;

AGED; AMINOLEVULINIC ACID; CANADA; CARBON RADIOISOTOPES; CYSTOSCOPY; DIAGNOSIS, DIFFERENTIAL; EUROPE; FEMALE; FLUORESCENCE; FOLLOW-UP STUDIES; HUMANS; MALE; MORBIDITY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84862154878     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.03.007     Document Type: Article

References (15)

1. P. Jichlinski, L. Guillou, S.J. Karlsen Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for the photodiagnosis of superficial bladder cancer - a multicenter study J Urol 170 2003 226
2. J. Schmidbauer, F. Witjes, N. Schmeller Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy J Urol 171 2004 135
3. D. Jocham, F. Witjes, S. Wagner Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study J Urol 174 2005 862
4. Y. Fradet, H.B. Grossman, L. Gomella A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study J Urol 178 2007 68
5. H.B. Grossman, L. Gomella, Y. Fradet A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer J Urol 178 2007 62
6. A. Stenzl, M. Burger, Y. Fradet Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer J Urol 184 2010 1907
7. D. Zaak, W.F. Wieland, C.G. Stief Routine use of photodynamic diagnosis of bladder cancer: practical and economic issues Eur Urol 7 suppl 2008 536
8. P.U. Malmstrom, H. Hedelin, Y.K. Thomas Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden Scand J Urol Nephrol 43 2009 192
9. G.D. Steinberg Editorial comment J Urol 184 2010 1913
10. M. Kriegmair, R. Baumgartner, R. Knuechel Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid Urology 44 1994 836
11. M.C. Schumacher, S. Holmang, T. Davidsson Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study Eur Urol 57 2010 293
12. M. Babjuk, V. Soukup, R. Petrik 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer BJU Int 96 2005 798
13. D.I. Daniltchenko, C.R. Riedl, M.D. Sachs Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study J Urol 174 2005 2129
14. S. Denzinger, M. Burger, B. Walter Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study Urology 69 2007 675
15. B. Geavlete, R. Multescu, D. Georgescu Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)? BJU Int 109 2012 549